Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 15:01:09 UTC 2023
by
admin
on
Sat Dec 16 15:01:09 UTC 2023
|
| Protein Sub Type | |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
66UL4XJJ3X
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
P43119
Created by
admin on Sat Dec 16 15:01:10 UTC 2023 , Edited by admin on Sat Dec 16 15:01:10 UTC 2023
|
PRIMARY | |||
|
66UL4XJJ3X
Created by
admin on Sat Dec 16 15:01:10 UTC 2023 , Edited by admin on Sat Dec 16 15:01:10 UTC 2023
|
PRIMARY |
| From | To |
|---|---|
| 1_5 | 1_165 |
| 1_92 | 1_170 |
| Glycosylation Type | HUMAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_7 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
AGONIST -> TARGET |
EC50
|
||
|
|
AGONIST -> TARGET |
|
||
|
AGONIST -> TARGET |
|
||
|
AGONIST -> TARGET |
ACT-333679 is 37-fold more potent than selexipag towards prostacyclin IP receptor.
IC50
|
||
|
AGONIST -> TARGET |
|
||
|
AGONIST -> TARGET |
|
||
|
AGONIST -> TARGET |
|
||
|
|
AGONIST -> TARGET |
BINDING
IC50
|
||
|
AGONIST -> TARGET |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|